Structure Database (LMSD)

Back

LMSD: Lipid classification search results

Show all lipids with this classification Show all lipids assigned to this classification.
Show only primary classification Show only those lipids which have been assigned to this class as the primary classification.
Show only secondary classifications Show only lipids which have this functionality but are not primarily assigned to this class.

Branched fatty acids [FA0102]

LM_ID Common Name Systematic Name Species Shorthand Formula Mass
LMFA01030981 3-Methylsubericacid 3-methylsuberic acid FA 9:1;O2 C9H16O4 188.104860
LMFA01030982 4-ene-Valproic acid 2-propylpent-4-enoic acid FA 8:1 C8H14O2 142.099380
LMFA01030983 4-Ethyloctanoic acid 4-ethyloctanoic acid FA 10:0 C10H20O2 172.146330
LMFA01030985 4-Methyl-2-pentenoic acid (2Z)-4-methylpent-2-enoic acid FA 6:1 C6H10O2 114.068080
LMFA01030994 8-Methylnonenoic acid (6E)-8-methylnon-6-enoic acid FA 10:1 C10H18O2 170.130680
LMFA01031015 mediomycin A (2E,4E,6E,10E,13S,14S,15R,16E,18E,20E,22E,24E,26E,33R,35S,36E,39S,41R,43S,44E,47R,49S,50E,53R,55S)-58-amino-13,15,33,35,39,41,43,47,49,53,55-undecahydroxy-2,12,14,30-tetramethyl-31-oxo-29-(sulfooxy)octapentaconta-2,4,6,10,16,18,20,22,24,26,36,44,50-tridecaenoic acid C62H97NO18S 1175.642641
LMFA01031016 mediomycin B (2E,4E,6E,10E,13S,14S,15R,16E,18E,20E,22E,24E,26E,33R,35S,36E,39S,41R,43S,44E,47R,49S,50E,53R,55S)-58-amino-13,15,29,33,35,39,41,43,47,49,53,55-dodecahydroxy-2,12,14,30-tetramethyl-31-oxooctapentaconta-2,4,6,10,16,18,20,22,24,26,36,44,50-tridecaenoic acid C62H97NO15 1095.685824
LMFA08020162 (E,E)-2,4-Decadienoic isobutylamide (2E,4Z)-N-(2-methylpropyl)deca-2,4-dienamide NA 14:2 C14H25NO 223.193614
LMFA08020164 2,4-Undecadiene-8,10-diynoic acid isobutylamide (2E,4Z)-N-(2-methylpropyl)undeca-2,4-dien-8,10-diynamide NA 15:6 C15H19NO 229.146664
LMFA08020165 Anacyclin (2E,4E)-N-isobutyltetradeca-2,4-dien-8,10-diynamide NA 18:6 C18H25NO 271.193614
LMFA08020167 beta-sanshool (2E,6E,8E,10E)-N-(2-methylpropyl)dodeca-2,6,8,10-tetraenamide NA 16:4 C16H25NO 247.193614
LMFA08020168 BRN 2646116 (2E,4E)-N-isobutyl-6-phenyl-hexa-2,4-dienamide NA 16:6 C16H21NO 243.162314
LMFA08020172 EI-1511-3 (2E,4E)-N-[(1S,5S,6R)-5-hydroxy-5-{(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trien-1-yl}-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-7-methylocta-2,4-dienamide C27H30N2O7 494.205303
LMFA08020173 EI-1511-5 (2E,4E,6E)-N-[(1S,5S,6R)-5-hydroxy-5-{(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trien-1-yl}-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-8-methyldeca-2,4,6-trienamide C29H32N2O7 520.220953
LMFA08020174 EI-1625-2 (2E)-N-[(1S,5R,6R)-5-hydroxy-5-{(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trien-1-yl}-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-4-methyloct-2-enamide C27H32N2O7 496.220953
LMFA08020176 FR901463 6-[(1E,3E)-5-(5-{[(2Z)-4-(acetyloxy)pent-2-enoyl]amino}-3,6-dimethyltetrahydro-2H-pyran-2-yl)-3-methylpenta-1,3-dien-1-yl]-4-C-(chloromethyl)-1,3-dideoxy-alpha-D-erythro-hex-2-ulopyranose C27H42NO8Cl 543.259897
LMFA08020177 FR901464 (2S,3Z)-5-{[(2R,3R,5S,6S)-6-{(2E,4E)-5-[(3R,4R,5R,7S)-4,7-dihydroxy-7-methyl-1,6-dioxaspiro[2.5]oct-5-yl]-3-methylpenta-2,4-dien-1-yl}-2,5-dimethyltetrahydro-2H-pyran-3-yl]amino}-5-oxopent-3-en-2-yl acetate NA 27:7;O7 C27H41NO8 507.283219
LMFA08020178 FR901465 (2S,3Z)-5-{[(2R,3R,5S,6S)-2,5-dimethyl-6-{(2E,4E)-3-methyl-5-[(3R,4R,5R,7S,8R)-4,7,8-trihydroxy-7-methyl-1,6-dioxaspiro[2.5]oct-5-yl]penta-2,4-dien-1-yl}tetrahydro-2H-pyran-3-yl]amino}-5-oxopent-3-en-2-yl acetate NA 27:7;O8 C27H41NO9 523.278134
LMFA08020179 gamma-sanshool N-(2-methylpropyl)tetradeca-2E,4E,8Z,10E,12E-pentaenamide NA 18:5 C18H27NO 273.209264
LMFA08020180 Herculin (2E,8E)-N-(2-methylpropyl)dodeca-2,8-dienamide NA 16:2 C16H29NO 251.224914
LMFA08020181 Hydroxy-epsilon-sanshool (2E,6Z,8E,10Z)-N-(2-hydroxy-2-methylpropyl)dodeca-2,6,8,10-tetraenamide NA 16:4;O C16H25NO2 263.188529
LMFA08020185 manumycin (2E,4E,6R)-N-[(1S,5S,6R)-5-hydroxy-5-[(1E,3E,5E)-7-[(2-hydroxy-5-oxo-cyclopenten-1-yl)amino]-7-oxo-hepta-1,3,5-trienyl]-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-2,4,6-trimethyl-deca-2,4-dienamide C31H38N2O7 550.267903
LMFA08020186 N-(2-Hydroxyisobutyl)-2,4,8,10,12-tetradecapentaenamide (2E,4E,8E,10E,12E)-N-(2-hydroxy-2-methylpropyl)tetradeca-2,4,8,10,12-pentaenamide NA 18:5;O C18H27NO2 289.204179
LMFA08020189 N,2,3-Trimethyl-2-(1-methylethyl)butanamide N,2,3-trimethyl-2-(propan-2-yl)butanamide NA 10:0 C10H21NO 171.162314
LMFA08020192 Neopellitorine A (2E,4E)-N-(2-methylpropyl)undeca-2,4-dien-7,9-diynamide NA 15:6 C15H19NO 229.146664
LMFA08020195 N-Isobutyl-2,4,8,10,12-tetradecapentaenamide (2E,4E,8E,10E,12E)-N-(2-methylpropyl)tetradeca-2,4,8,10,12-pentaenamide NA 18:5 C18H27NO 273.209264
LMFA08020198 Pantothenol (2R)-2,4-dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutanamide NA 9:0;O3 C9H19NO4 205.131409
LMFA08020200 Pipericine (2E,4E)-N-(2-methylpropyl)octadeca-2,4-dienamide NA 22:2 C22H41NO 335.318814
LMFA08020204 TMC-1A (2E)-N-[(3S,4R)-3,4-dihydroxy-3-{(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trien-1-yl}-6-oxocyclohex-1-en-1-yl]-2,4-dimethyloct-2-enamide C28H36N2O7 512.252253
LMFA08020205 TMC-1C (2E,4E)-N-[(3S,4R)-3,4-dihydroxy-3-[(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)amino]-7-oxohepta-1,3,5-trienyl]-6-oxocyclohex-1-en-1-yl]-4,6-dimethyldeca-2,4-dienamide C30H38N2O7 538.267903
LMFA08020206 TMC-1D (2E)-N-[(3S,4R)-3,4-dihydroxy-3-[(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopenten-1-yl)amino]-7-oxohepta-1,3,5-trienyl]-6-oxocyclohexen-1-yl]-4,6-dimethyldec-2-enamide C30H40N2O7 540.283553
LMFA08010022 S-(2-Methylpropionyl)-dihydrolipoamide-E 8-[(2-methylpropanoyl)sulfanyl]-6-sulfanyloctanamide C12H23NO2S2 277.117023
LMFA08010024 Sakacin P tert-butyl N-(1-carbamoyl-1-oxopropan-2-yl)carbamate C9H16N2O4 216.111008
LMFA07070029 2,6 dimethylheptanoyl carnitine 3-[(2,6-dimethylheptanoyl)oxy]-4-(trimethylazaniumyl)butanoate CAR 9:0 C16H31NO4 301.225309
LMFA07070030 2-ethylacryloylcarnitine 3-[(2-methylidenebutanoyl)oxy]-4-(trimethylammonio)butanoate CAR 5:1 C12H21NO4 243.147059
LMFA07070034 2-Methylbutyroylcarnitine 3-[(2-methylbutanoyl)oxy]-4-(trimethylazaniumyl)butanoate CAR 5:0 C12H23NO4 245.162709
LMFA07070041 3-hydroxyisovalerylcarnitine 3-[(3-hydroxy-3-methylbutanoyl)oxy]-4-(trimethylazaniumyl)butanoate CAR 5:0;O C12H23NO5 261.157624
LMFA07070046 4,8 dimethylnonanoyl carnitine 3-[(4,8-dimethylnonanoyl)oxy]-4-(trimethylazaniumyl)butanoate CAR 11:0 C18H35NO4 329.256609
LMFA07070073 hydroxyisovaleroyl carnitine 3-hydroxy-3-isovaleryloxy-4-(trimethylammonio)butyrate CAR 5:0;O C12H23NO5 261.157624
LMFA07070075 Isobutyryl-L-carnitine 3-[(2-methylpropanoyl)oxy]-4-(trimethylazaniumyl)butanoate CAR 4:0 C11H21NO4 231.147059
LMFA07070076 Isovalerylcarnitine 3-[(3-methylbutanoyl)oxy]-4-(trimethylazaniumyl)butanoate CAR 5:0 C12H23NO4 245.162709
LMFA07070077 isovaleryl-L-carnitine (3R)-3-[(3-methylbutanoyl)oxy]-4-(trimethylazaniumyl)butanoate CAR 5:0 C12H23NO4 245.162709
LMFA07070081 Methylmalonylcarnitine (3S)-3-[(2-carboxy-2-methylacetyl)oxy]-4-(trimethylazaniumyl)butanoate CAR 4:1;O2 C11H19NO6 261.121239
LMFA07070094 O-methylmalonylcarnitine 3-[(2-carboxypropanoyl)oxy]-4-(trimethylazaniumyl)butanoate CAR 4:1;O2 C11H19NO6 261.121239
LMFA07070103 pivaloylcarnitine 3-[(2,2-dimethylpropanoyl)oxy]-4-(trimethylazaniumyl)butanoate CAR 5:0 C12H23NO4 245.162709
LMFA07070108 Tiglylcarnitine 3-{[(2E)-2-methylbut-2-enoyl]oxy}-4-(trimethylazaniumyl)butanoate CAR 5:1 C12H21NO4 243.147059
LMFA07050092 (11Z)-3-oxoicosa-11-enoyl-CoA 3-oxo-11Z-eicosenoyl-CoA CoA 20:2;O C41H70N7O18P3S 1073.371099
LMFA07050093 (11Z)-eicosenoyl-CoA 11Z-eicosenoyl-CoA CoA 20:1 C41H72N7O17P3S 1059.391834
LMFA07050094 (11Z,14Z)-3-oxoicosa-11,14-dienoyl-CoA 3-oxo-11Z,14Z-eicosadienoyl-CoA CoA 20:3;O C41H68N7O18P3S 1071.355449
LMFA07050095 (11Z,14Z,17Z)-3-oxoicosatrienoyl-CoA 3-oxo-11Z,14Z,17Z-eicosatrienoyl-CoA CoA 20:4;O C41H66N7O18P3S 1069.339799